chemotherapy - malecare.org

Rapid PSA Decline After Docetaxel Chemotherapy is Associated with Improved Survival in Hormone Refractory Prostate Cancer

A chart review performed at the Department of Internal Medicine, University of Alberta, Edmonton, AB. concluded that the a quick rate of initial PSA decline in men with hormone refractory prostate cancer receiving docetaxel chemotherapy (chemo) predicts an increased overall survival (OS). Studies have demonstrated that docetaxel chemotherapy does prolong survival in metastatic hormone-refractory prostate [...]

By Malecare|2009-11-11T12:29:08-05:00November 11th, 2009|Advanced Prostate Cancer, Chemo Therapy, Drugs & Treatments, End-Of-Life, Uncategorized, Understanding APC|0 Comments

Scott Goodwin Checks In

Scott Goodwin who periodically has been writing about his journey taking chemotherapy has given us a very moving update. Sadly, Scott is not doing well physically, but he is continuing his valiant fight against this insipid disease. - JTN I thought I would send a much overdue update on my progress with chemo, etc. I [...]

By Malecare|2017-10-19T10:54:25-04:00October 27th, 2009|Advanced Prostate Cancer, Chemo Therapy, Clinical Trials, Clinical Trials, Hormone Therapy, Personal Experiences, Scott Godwin - Chemotherapy, Uncategorized, Understanding APC|12 Comments

On The Horizon- FDA Grants Fast Track Designation for OGX-011 in The Treatment of Prostate Cancer

OncoGenex Pharmaceuticals, Inc. (OGXI) announced that it's experimental product, OGX-011, also known as custirsen sodium, received fast track designation from the U.S. Food & Drug Administration (FDA) for the treatment of progressive metastatic prostate cancer in combination with first-line docetaxel treatment (chemotherapy). OGXI had previously received this same designation for second-line docetaxel treatment with OGX-011 [...]

By Malecare|2017-10-19T10:54:28-04:00October 12th, 2009|Advanced Prostate Cancer, Chemo Therapy, Chemo Therapy Failure, Clinical Trials, Clinical Trials, Drugs & Treatments, FDA, Metastases, On The Horizon, Uncategorized|0 Comments

The Name of The Game Is Life Extension

Advanced prostate cancer will progress and most of us will face a time when Androgen Deprivation Therapy (ADT) stops working. Most men on ADT take a LHRH agonist, which turns off the production of testosterone (i.e. Lupron) along with a non-steroidal anti-androgen (i.e. Casodex) that prevents the small amount of testosterone that continues to be [...]

By Malecare|2017-10-19T10:54:34-04:00September 11th, 2009|Advanced Prostate Cancer, Chemo Therapy, Drugs & Treatments, Hormone Therapy, How We Live, Prostate Ponderings, Uncategorized, Understanding APC|0 Comments

Carboplatin-Taxane Combinations in the Management of Castration-resistant Prostate Cancer

The use of Docetaxel (chemotherapy) extends survival time in men with castration-resistant prostate cancer (CRPC). Many researchers believe that platinum compounds, particularly Carboplatin, when added to docetaxel (taxane-based chemotherapy) can further extend survival times. A study at the Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Investigated the efficacy [...]

By Malecare|2020-02-04T11:38:11-05:00September 3rd, 2009|Advanced Prostate Cancer, Chemo Therapy, Clinical Trials, Drugs & Treatments, Uncategorized|0 Comments